Hepatitis C knowledge among staff in U.S. drug treatment programs

Journal of Drug Education

Volumn 36, Issue 2, 2006, Pages 141-158

  Strauss, Shiela M ^a   Astone Twerell, Janetta M ^a   Munoz Plaza, Corrine ^a   Des Jarlais, Don C ^b   Gwadz, Marya ^a   Hagan, Holly ^a   Osborne, Andrew ^a   Rosenblum, Andrew ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL STAFF; NORMAL HUMAN; PERSONNEL MANAGEMENT; STAFF TRAINING; UNITED STATES; ATTITUDE TO HEALTH; DRUG DEPENDENCE TREATMENT; HEALTH CARE PERSONNEL; MIDDLE AGED; QUESTIONNAIRE;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES;

EID: 33947536982     PISSN: 00472379     EISSN: 15414159     Source Type: Journal    
DOI: 10.2190/3EMQ-N350-W4XN-WT1X     Document Type: Article

References (57)

1. M. J. Alter, D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, and F. Gao, The Prevalence of Hepatitis C Virus Infection in the United States, 1988 Through 1994, New England Journal of Medicine, 341(8), pp. 556-62, 1999.
2. M. J. Alter and L. A. Moyer, The Importance of Preventing Hepatitis C Virus Infection among Injection Drug Users in the United States, Journal of Acquired Immune Deficiency Syndromes, 18, pp. S6-S10, 1998.
3. H. Hagan, H. Thiede, N. S. Weiss, S. G. Hopkins, J. S. Duchin, and E. R. Alexander, Sharing of Drug Preparation Equipment Associated with Hepatitis C Virus Seroconversion in Drug Injectors, American Journal of Public Health, 91, pp. 42-46, 2001.
4. I. Williams, Epidemiology of Hepatitis C in the United States, American Journal of Medicine, 107, pp. 2S-9S, 1999.
5. M. J. Alter, Epidemiology of Hepatitis C, Hepatology, 26, pp. 62S-65S, 1997.
6. H. Hagan, J. P. McGough, H. Thiede, N. S. Weiss, S. Hopkins, and E. R. Alexander, Syringe Exchange and Risk of HBV and HCV in Seattle IDUs, American Journal of Epidemiology, 149, pp. 203-213, 1999.
7. J. Lorvick, A. H. Kral, K. Seal, L. Gee, and B. R. Edlin, Prevalence and Duration of Hepatitis C among Injection Drug Users in San Francisco, California, American Journal of Public Health, 91, pp. 46-47, 2001.
8. J. J.McCarthy and N. Flynn, Hepatitis C in Methadone Maintenance Patients: Prevalence and Public Policy Implications, Journal of Addictive Diseases, 20, pp. 19-31, 2001.
9. M. J. Alter, Prevention of Spread of Hepatitis C, Hepatology, 36(5 Suppl 1), pp. S93-S98, 2002.
10. R. S. Garfein, M. C. Doherty, E. R. Monterroso, D. L. Thomas, K. E. Nelson, and D. Vlahov, Prevalence and Incidence of Hepatitis C Virus Infection among Young Adult Injection Drug Users, Journal of Acquired Immune Deficiency Syndromes, 18(Suppl 1), pp. S11-S19, 1998.
11. J. A. Hahn, K. Page-Shafer, P. J. Lum, K. Ochoa, and A. R. Moss, Hepatitis C Virus Infection and Needle Exchange Use among Young Injection Drug Users in San Francisco, Hepatology, 34, pp. 180-187, 2001.
12. L. E. Thorpe, L. J. Ouellet, R. Hershow, S. L. Bailey, I. T. Williams, J. Williamson, and E. R. Monterroso, Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment, American Journal of Epidemiology, 155, pp. 645-653, 2002.
13. S. D. Rosenberg, L. A. Goodman, and F. C. Osher, Prevalence of HIV, Hepatitis B, and Hepatitis C in People with Severe Mental Illness, American Journal of Public Health, 91, pp. 42-46, 2001.
14. A. Rosenblum, L. Nuttbrock, H. L. McQuistion, S. Magura, and H. Joseph, Hepatitis C and Substance Use in a Sample of Homeless People in New York City, Journal of Addictive Diseases, 20(4), pp. 15-25, 2001.
15. S. Tortu, A. Neaigus, J. McMahon, and D. Hagen, Hepatitis C among Non-Injecting Drug Users: A Report, Substance Use and Misuse, 36, pp. 523-534, 2001.
16. Centers for Disease Control and Prevention, Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease, Morbidity and Mortality Weekly Reports, 47, pp. 1-39, 1998.
17. A. J. Freeman, G. J. Dore, M. G. Law, M. Thorpe, J. Von Overbeck, A. R. Lloyd, G. Marinos, and J. M. Kaldor, Estimating Progression to Cirrhosis in Chronic Hepatitis C Virus Infection, Hepatology, 34(4 Pt 1), pp. 809-816, 2001.
18. T. J. Liang, B. Rehermann, L. B. Seeff, and J. H. Hoofnagle, Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C, Annals of Internal Medicine, 132, pp. 296-305, 2000.
19. G. M. Bhopale and R. K. Nanda, Prospects for Hepatitis C Vaccine, Acta Virologica, 48(4), pp. 215-221, 2004.
20. A. M. Di Bisceglie and J. H. Hoofnagle, Optimal Therapy of Hepatitis C, Hepatology, 36, pp. S121-S127, 2002.
21. M. W. Fried, M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu, Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, 347(13), pp. 975-982, 2002.
22. D. Best, A. Noble, E. Finch, M. Gossop, C. Sidwell, and J. Strang, Accuracy of Perceptions of Hepatitis B and C Status: Cross Sectional Investigation of Opiate Addicts in Treatment, British Medical Journal, 319, pp. 290-291, 1999.
23. M. Davis, T. Rhodes, and A. Martin, Preventing Hepatitis C: 'Common Sense', 'the Bug' and Other Perspectives from the Risk Narratives of People Who Inject Drugs, Social Science and Medicine, 59(9), pp. 1807-1818, 2004.
24. V. P. Dhopesh, K. R. Taylor, and W. M. Burke, Survey of Hepatitis B and C in an Addiction Treatment Unit, American Journal of Drug and Alcohol Abuse, 26(4), pp. 703-707, 2000.
25. R. Heimer, S. Clair, L. E. Grau, R. N. Bluthenthal, P. A. Marshall, and M. Singer, Hepatitis-Associated Knowledge is Low and Risks are High among HIV-Aware Injection Drug Users in Three US Cities, Addiction, 97(10), pp. 1277-1287, 2002.
26. C. F. Kwiatkowski, K. F. Corsi, and R. E. Booth, The Association between Knowledge of Hepatitis C Virus Status and Risk Behaviors in Injection Drug Users, Addiction, 97, pp. 1289-1294, 2002.
27. T. Rhodes, M. Davis, and A. Judd, Hepatitis C and Its Risk Management among Drug Injectors in London: Renewing Harm Reduction in the Context of Uncertainty, Addiction, 99(5), pp. 621-633, 2004.
28. M. D. Stein, J. Maksad, and J. Clarke, Hepatitis C Disease among Injection Drug Users: Knowledge, Perceived Risk and Willingness to Receive Treatment, Drug and Alcohol Dependence, 61, pp. 211-215, 2001.
29. A. Y. Walley, M. White, Y. Song, M. Kushell, and J. P. Tulsky, Women Methadone Clients are Less Knowledgeable about Hepatitis C Treatment. Poster presented at the sixty-fifth annual scientific meeting of the College on Problems of Drug Dependence, Bal Harbour, FL., June 16, 2003.
30. D. E. Nicklin, C. Schultz, C. M. Brensinger, and J. P. Wilson, Current Care of Hepatitis C-Positive Patients By Primary Care Physicians in an Integrated Delivery System, Journal of the American Board of Family Practitioners, 12(6), pp. 497-500, 1999.
31. A. G. Coppola, P. C. Karakousis, D. C. Metz, M. F. Go, M. Mhokashi, C. W. Howden, J. P. Raufman, and V. K. Sharma, Hepatitis C Knowledge among Primary Care Residents: Is Our Teaching Adequate for the Times? American Journal of Gastroenterology, 99(9), pp. 1720-1725, 2004.
32. L. R. Fischer, K. S. Conboy, D. H. Tope, and D. K. Shewmake, Educating Health Professionals: A Hepatitis C Educational Program in a Health Maintenance Organization, American Journal of Managed Care, 6, pp. 1029-1036, 2000.
33. T. M. Shehab, S. S. Sonnad, and A. S. F. Lok, Management of Hepatitis C by Primary Care Physicians in the USA: Results of a National Survey. Journal of Viral Hepatitis, 8, pp. 377-383, 2001.
34. C. A. Smith, M. Johnson, and L. S. Brown, Hepatitis C Knowledge Base of Providers Caring for HIV Positive Communities of Color [Abstract 902], 39th Annual Meeting of the Infectious Diseases Society of America, October 25-28, 2001, San Francisco, Calif.
35. N. Crofts, R. Louie, and B. Loff, The Next Plague: Stigmatization and Discrimination Related to Hepatitis C Virus Infection in Australia, Health and Human Rights, 2(2), pp. 87-97, 1997.
36. C. Day, J. Ross, and K. Dolan, Hepatitis C-Related Discrimination among Heroin Users in Sydney: Drug User or Hepatitis C Discrimination? Drug and Alcohol Review, 22(3), pp. 317-321, 2003.
37. B. R. Edlin, K. H. Seal, J. Lorvick, A. H. Kral, D. H. Ciccarone, L. D. Moore, and B. Lo, Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users? New England Journal of Medicine, 345, pp. 211-215, 2001.
38. J. Stephenson, Former Addicts Face Barriers to Treatment for HCV, Journal of the American Medical Association, 285(8), pp. 1003-1005, 2001.
39. C.J. Treloar, M. N. Hopwood, and S. K. Loveday, Hepatitis C-Related Discrimination in Healthcare. Report of the Third Australasian Conference on Hepatitis C, Melbourne, March 2002, Medical Journal of Australia, 177(5), pp. 233-234, 2002.
40. S. Zickmund, S. L. Hillis, M. J. Barnett, L. Ippolito, and D. R. LaBrecque, Hepatitis C Virus-Infected Patients Report Communication Problems with Physicians, Hepatology, 39, pp. 999-1007, 2004.
41. S. Zickmund, E. Y. Ho, M. Masuda, L. Ippolito, and D. R. LaBrecque, "They Treated Me Like a Leper." Stigmatization and the Quality of Life of Patients with Hepatitis C, Journal of General Internal Medicine, 18(10), pp. 835-844, 2003.
42. T. D'Aunno, T. E. Vaughn, and P. McElroy, An Institutional Analysis of HIV Prevention Efforts by the Nation's Outpatient Drug Abuse Treatment Units, Journal of Health and Social Behavior, 40, pp. 175-192, 1999.
43. M. N. Gourevitch, W. Wasserman, M. S. Panero, and P. A. Selwyn, Successful Adherence to Observed Prophylaxis and Treatment of Tuberculosis among Drug Users in a Methadone Program, Journal of Addictive Diseases, 15(1), pp. 93-104, 1996.
44. U. Sambamoorthi, L. A. Warner, S. Crystal, and J. Walkup, Drug Abuse, Methadone Treatment, and Health Services Use among Injection Drug Users with AIDS, Drug and Alcohol Dependence, 60, pp. 77-89, 2000.
45. J. L. Sorensen, C. L. Masson, and D. C. Perlman, HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance from Research, Science and Practice Perspectives, 1, pp. 4-11, 2002.
46. J. M. Astone-Twerell, S. M. Strauss, H. Hagan, and D. C. Des Jarlais, Providing Support to Drug Users Infected with Hepatitis C: The Role of Methadone Maintenance Treatment Staff, Journal of Maintenance in the Addictions, 3(1), pp. 33-46, 2005.
47. H. V. McCoy, S. E. Messiah, and W. Zhao, Improving Access to Primary Health Care for Chronic Drug Abusers: An Innovative Systematic Intervention for Providers, The Journal of Behavioral Health Services and Research, 29, pp. 445-457, 2002.
48. D. S. Morrison, G. Gilchrist, and S. Ahmed, Potential of Specialist Drug Services to Deliver Hepatitis B Vaccination, Communicable Diseases and Public Health, 5(4), pp. 321-323, 2002.
49. S. M. Strauss, J. M. Astone, C. Munoz-Plaza, H. Hagan, and D. C. Des Jarlais, Residential Drug Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives, Substance Use and Misuse, 40(12), pp. 1811-1829, 2005.
50. W. R. Miller, G. Benefield, and J. Tonigan, Enhancing Motivation for Change in Problem Drinking: A Controlled Comparison of Two Therapist Styles, Journal of Consulting and Clinical Psychology, 61, pp. 455-461, 1993.
51. J. E. Zweben, Hepatitis C: Education and Counseling Issues, Journal of Addictive Diseases, 20(1), pp. 33-42, 2001.
52. B. E. Landon, I. B. Wilson, N. S. Wenger, S. E. Cohn, C. J. Fichtenbaum, S. A. Bozzette, M. F. Shapiro, and P. D. Cleary, Specialty Training and Specialization Among Physicians Who Treat HIV/AIDS in the United States, Journal of General Internal Medicine, 17(1), pp. 12-22, 2002.
53. C.-C. N. U. Pratt, D. Paone, B. J. Carter, and M. C. Layton, Hepatitis C Screening and Management Practices: A Survey of Drug Treatment and Syringe Exchange Programs in New York City, American Journal of Public Health, 92, pp. 1254-1256, 2002.
54. S. M. Strauss, J. Astone, Z. P. Vassilev, D. C. Des Jarlais, and H. Hagan, Gaps in the Drug-Free and Methadone Treatment Program Response to Hepatitis C, Journal of Substance Abuse Treatment, 24(4), pp. 291-297, 2003.
55. S. M. Strauss, G. P. Falkin, Z. Vassilev, D. C. Des Jarlais, and J. Astone, A Nationwide Survey of Hepatitis C Services Provided by Drug Treatment Programs, Journal of Substance Abuse Treatment, 22(2), pp. 55-62, 2002.
56. D. D. Chitwood, D. C. McBride, M. T. French, and M. Comerford, Health Care Need and Utilization: A Preliminary Comparison of Injection Drug Users, Other Illicit Drug Users, and Nonusers, Substance Use and Misuse, 34(4-5), pp. 727-746, 1999.
57. S. Tortu, J. McMahon, E. Pouget, and R. Hamid, Sharing of Non-Injection Drug Use Implements as a Risk Factor for Hepatitis C, Substance Use and Misuse, 39(2), pp. 211-224, 2004.